Cancer care continuum: Prevention > Detection > Diagnosis > Treatment > Survivorship
Diagnosis is the third phase in the cancer care continuum. This phase focuses on the pathology of cancer. Research interests from our faculty members lies around biomarkers that may put specific sub-populations at a greater risk for certain cancers.
Faculty Involved: Erika Waters, Jean Hunleth
Drs. Waters, Hunleth, and colleagues will used a mixed methods research design to gain in-depth understanding of the psychological and social factors that shape the decision making process that caregivers use to care for their asthmatic children. This project will provide evidence-based behavioral strategies to improve the lives of 6.2 million children who are affected by asthma.
Faculty involved: Aimee James, Siobhan Sutcliffe
The PLUS Research Network is a multi-site network designed to develop the evidence base for future clinical trials to prevent the development and progression of lower urinary tract symptoms in women and girls. Current projects include a qualitative focus group study, the development of new instruments to measure bladder health, systematic reviews of the literature, and analyses of existing study data to better understand bladder health and factors that contribute to the development and progression of lower urinary tract symptoms.
Faculty involved: Aimee James, Graham Colditz, Vetta Sanders Thompson, Bettina Drake, Esther Lu, Jean Hunleth
Community-based participatory research (CBPR) helps give community members voice in academic research. These projects evaluated current and past CBPR projects to discovery future best practices.
Faculty involved: Graham Colditz, Aimee James, Bettina Drake, Vetta Sanders Thompson
The mission of Siteman Cancer Center’s Program for the Elimination of Cancer Disparities (PECaD) is to create a national model for eliminating local and regional disparities in cancer education, prevention and treatment. Through a community advisory committee and community partnerships, PECaD works with community representatives to find solutions that reduce disparities.
Faculty involved: Bettina Drake, Graham Colditz
The long-term goal of this collaboration between Dr. Drake and The St. Louis Mens Group Against Cancer is to be able to identify patients with increased risk for dying of prostate cancer while they are still treatable.
Faculty involved: Adetunji Toriola, Graham Colditz, Rosy Luo
A very dense breast on mammogram is one of the strongest risk factors for breast cancer, and many women in the United States have extremely dense breasts. There is, however, very limited knowledge on how to modify breast density to reduce breast cancer risk